Corrigendum: Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2020-11-01
|
| Series: | Frontiers in Pediatrics |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2020.610461/full |
| id |
doaj-564600662ed146e48c43dbd0a6193f94 |
|---|---|
| record_format |
Article |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Olubukola T. Idoko Olubukola T. Idoko Olubukola T. Idoko Olubukola T. Idoko Kinga K. Smolen Kinga K. Smolen Oghenebrume Wariri Abdulazeez Imam Casey P. Shannon Tida Dibassey Joann Diray-Arce Joann Diray-Arce Alansana Darboe Julia Strandmark Rym Ben-Othman Oludare A. Odumade Oludare A. Odumade Oludare A. Odumade Kerry McEnaney Kerry McEnaney Nelly Amenyogbe William S. Pomat Simon van Haren Simon van Haren Guzmán Sanchez-Schmitz Guzmán Sanchez-Schmitz Ryan R. Brinkman Ryan R. Brinkman Hanno Steen Hanno Steen Hanno Steen Robert E. W. Hancock Scott J. Tebbutt Scott J. Tebbutt Scott J. Tebbutt Peter C. Richmond Peter C. Richmond Anita H. J. van den Biggelaar Tobias R. Kollmann Ofer Levy Ofer Levy Ofer Levy Al Ozonoff Al Ozonoff Beate Kampmann Beate Kampmann |
| spellingShingle |
Olubukola T. Idoko Olubukola T. Idoko Olubukola T. Idoko Olubukola T. Idoko Kinga K. Smolen Kinga K. Smolen Oghenebrume Wariri Abdulazeez Imam Casey P. Shannon Tida Dibassey Joann Diray-Arce Joann Diray-Arce Alansana Darboe Julia Strandmark Rym Ben-Othman Oludare A. Odumade Oludare A. Odumade Oludare A. Odumade Kerry McEnaney Kerry McEnaney Nelly Amenyogbe William S. Pomat Simon van Haren Simon van Haren Guzmán Sanchez-Schmitz Guzmán Sanchez-Schmitz Ryan R. Brinkman Ryan R. Brinkman Hanno Steen Hanno Steen Hanno Steen Robert E. W. Hancock Scott J. Tebbutt Scott J. Tebbutt Scott J. Tebbutt Peter C. Richmond Peter C. Richmond Anita H. J. van den Biggelaar Tobias R. Kollmann Ofer Levy Ofer Levy Ofer Levy Al Ozonoff Al Ozonoff Beate Kampmann Beate Kampmann Corrigendum: Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea Frontiers in Pediatrics markers newborn vaccine immunogenicity systems biology OMICS |
| author_facet |
Olubukola T. Idoko Olubukola T. Idoko Olubukola T. Idoko Olubukola T. Idoko Kinga K. Smolen Kinga K. Smolen Oghenebrume Wariri Abdulazeez Imam Casey P. Shannon Tida Dibassey Joann Diray-Arce Joann Diray-Arce Alansana Darboe Julia Strandmark Rym Ben-Othman Oludare A. Odumade Oludare A. Odumade Oludare A. Odumade Kerry McEnaney Kerry McEnaney Nelly Amenyogbe William S. Pomat Simon van Haren Simon van Haren Guzmán Sanchez-Schmitz Guzmán Sanchez-Schmitz Ryan R. Brinkman Ryan R. Brinkman Hanno Steen Hanno Steen Hanno Steen Robert E. W. Hancock Scott J. Tebbutt Scott J. Tebbutt Scott J. Tebbutt Peter C. Richmond Peter C. Richmond Anita H. J. van den Biggelaar Tobias R. Kollmann Ofer Levy Ofer Levy Ofer Levy Al Ozonoff Al Ozonoff Beate Kampmann Beate Kampmann |
| author_sort |
Olubukola T. Idoko |
| title |
Corrigendum: Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea |
| title_short |
Corrigendum: Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea |
| title_full |
Corrigendum: Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea |
| title_fullStr |
Corrigendum: Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea |
| title_full_unstemmed |
Corrigendum: Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea |
| title_sort |
corrigendum: clinical protocol for a longitudinal cohort study employing systems biology to identify markers of vaccine immunogenicity in newborn infants in the gambia and papua new guinea |
| publisher |
Frontiers Media S.A. |
| series |
Frontiers in Pediatrics |
| issn |
2296-2360 |
| publishDate |
2020-11-01 |
| topic |
markers newborn vaccine immunogenicity systems biology OMICS |
| url |
https://www.frontiersin.org/articles/10.3389/fped.2020.610461/full |
| work_keys_str_mv |
AT olubukolatidoko corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT olubukolatidoko corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT olubukolatidoko corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT olubukolatidoko corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT kingaksmolen corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT kingaksmolen corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT oghenebrumewariri corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT abdulazeezimam corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT caseypshannon corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT tidadibassey corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT joanndirayarce corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT joanndirayarce corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT alansanadarboe corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT juliastrandmark corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT rymbenothman corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT oludareaodumade corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT oludareaodumade corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT oludareaodumade corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT kerrymcenaney corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT kerrymcenaney corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT nellyamenyogbe corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT williamspomat corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT simonvanharen corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT simonvanharen corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT guzmansanchezschmitz corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT guzmansanchezschmitz corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT ryanrbrinkman corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT ryanrbrinkman corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT hannosteen corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT hannosteen corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT hannosteen corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT robertewhancock corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT scottjtebbutt corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT scottjtebbutt corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT scottjtebbutt corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT petercrichmond corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT petercrichmond corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT anitahjvandenbiggelaar corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT tobiasrkollmann corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT oferlevy corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT oferlevy corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT oferlevy corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT alozonoff corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT alozonoff corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT beatekampmann corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea AT beatekampmann corrigendumclinicalprotocolforalongitudinalcohortstudyemployingsystemsbiologytoidentifymarkersofvaccineimmunogenicityinnewborninfantsinthegambiaandpapuanewguinea |
| _version_ |
1724421852384722944 |
| spelling |
doaj-564600662ed146e48c43dbd0a6193f942020-11-25T04:09:46ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602020-11-01810.3389/fped.2020.610461610461Corrigendum: Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New GuineaOlubukola T. Idoko0Olubukola T. Idoko1Olubukola T. Idoko2Olubukola T. Idoko3Kinga K. Smolen4Kinga K. Smolen5Oghenebrume Wariri6Abdulazeez Imam7Casey P. Shannon8Tida Dibassey9Joann Diray-Arce10Joann Diray-Arce11Alansana Darboe12Julia Strandmark13Rym Ben-Othman14Oludare A. Odumade15Oludare A. Odumade16Oludare A. Odumade17Kerry McEnaney18Kerry McEnaney19Nelly Amenyogbe20William S. Pomat21Simon van Haren22Simon van Haren23Guzmán Sanchez-Schmitz24Guzmán Sanchez-Schmitz25Ryan R. Brinkman26Ryan R. Brinkman27Hanno Steen28Hanno Steen29Hanno Steen30Robert E. W. Hancock31Scott J. Tebbutt32Scott J. Tebbutt33Scott J. Tebbutt34Peter C. Richmond35Peter C. Richmond36Anita H. J. van den Biggelaar37Tobias R. Kollmann38Ofer Levy39Ofer Levy40Ofer Levy41Al Ozonoff42Al Ozonoff43Beate Kampmann44Beate Kampmann45Vaccines and Immunity Theme, Medical Research Council Unit the Gambia at London School of Hygiene and Tropical Medicine, Fajara, GambiaPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United StatesCIH LMU Center for International Health, Medical Center of the University of Munich (LMU), Munich, GermanyThe Vaccine Centre, London School of Hygiene and Tropical Medicine, London, United KingdomPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United StatesHarvard Medical School, Boston, MA, United StatesVaccines and Immunity Theme, Medical Research Council Unit the Gambia at London School of Hygiene and Tropical Medicine, Fajara, GambiaVaccines and Immunity Theme, Medical Research Council Unit the Gambia at London School of Hygiene and Tropical Medicine, Fajara, GambiaPROOF Centre of Excellence, Vancouver, BC, CanadaVaccines and Immunity Theme, Medical Research Council Unit the Gambia at London School of Hygiene and Tropical Medicine, Fajara, GambiaPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United StatesHarvard Medical School, Boston, MA, United StatesVaccines and Immunity Theme, Medical Research Council Unit the Gambia at London School of Hygiene and Tropical Medicine, Fajara, GambiaVaccines and Immunity Theme, Medical Research Council Unit the Gambia at London School of Hygiene and Tropical Medicine, Fajara, GambiaDepartment of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, BC, CanadaPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United StatesThe Vaccine Centre, London School of Hygiene and Tropical Medicine, London, United KingdomDivision of Medicine Critical Care, Harvard Medical School, Boston Children's Hospital, Boston, MA, United StatesPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United StatesDepartment of Cardiology, Boston Children's Hospital, Boston, MA, United States0Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia1Papua New Guinea Institute of Medical Research, Goroka, Papua New GuineaPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United StatesHarvard Medical School, Boston, MA, United StatesPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United StatesHarvard Medical School, Boston, MA, United States2BC Cancer Agency, Vancouver, BC, Canada3Department of Medical Genetics, University of British Columbia, Vancouver, BC, CanadaPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United StatesHarvard Medical School, Boston, MA, United States4Department of Pathology, Boston Children's Hospital, Boston, MA, United States5Department of Microbiology & Immunology, University of British Columbia, Vancouver, BC, CanadaPROOF Centre of Excellence, Vancouver, BC, Canada6Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada7Division of Respiratory Medicine, Department of Medicine, UBC, Vancouver, BC, Canada0Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia8Division of Pediatrics, School of Medicine, Perth Children's Hospital, University of Western Australia, Nedlands, WA, Australia0Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia0Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Nedlands, WA, AustraliaPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United StatesHarvard Medical School, Boston, MA, United States9Broad Institute of MIT & Harvard, Cambridge, MA, United StatesPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United StatesHarvard Medical School, Boston, MA, United StatesVaccines and Immunity Theme, Medical Research Council Unit the Gambia at London School of Hygiene and Tropical Medicine, Fajara, GambiaThe Vaccine Centre, London School of Hygiene and Tropical Medicine, London, United Kingdomhttps://www.frontiersin.org/articles/10.3389/fped.2020.610461/fullmarkersnewbornvaccineimmunogenicitysystems biologyOMICS |